• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-内酰胺水解在产β-内酰胺酶的阴沟肠杆菌菌株对广谱β-内酰胺类抗生素耐药机制中的作用

Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.

作者信息

Vu H, Nikaido H

出版信息

Antimicrob Agents Chemother. 1985 Mar;27(3):393-8. doi: 10.1128/AAC.27.3.393.

DOI:10.1128/AAC.27.3.393
PMID:3873215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176283/
Abstract

Enterobacter cloacae strains producing chromosomally mediated beta-lactamase constitutively show high degrees of resistance to most of the third-generation beta-lactams. It has been proposed that this resistance is due to the nonhydrolytic binding or trapping of beta-lactams by the enzyme. We found that the outer membrane of E. cloacae strain 55M indeed had permeability to cefazolin about 14-fold lower than that of Escherichia coli, and that the number of beta-lactamase molecules produced by this constitutive mutant was exceptionally large (2 X 10(5) per cell). These conditions are expected to produce a low degree of resistance, but could not explain the high resistance level of the mutant. We showed that the beta-lactamase of this strain hydrolyzed third-generation beta-lactams at measurable rates. Although the V max for these compounds was less than 0.01% of that for cefazolin, the enzyme could hydrolyze them at rates comparable to the rate for cefazolin when the substrate concentration was near 0.1 microM, a concentration thought to be physiologically relevant for the inhibition of cell growth, because of the exceptionally high affinity of the enzyme to many third-generation compounds. Calculations based on kinetic parameters of the enzyme, outer membrane permeability, and affinity toward penicillin-binding proteins succeeded in predicting the MICs for several third-generation beta-lactams. The data suggest that hydrolysis may be more important than nonhydrolytic binding for the expression of the resistant phenotype, and that studies on the susceptibility of beta-lactams to beta-lactamases should be carried out at physiologically relevant, very low concentrations of the drug, rather than the customary very high concentrations, such as 100 microM.

摘要

产染色体介导的β-内酰胺酶的阴沟肠杆菌菌株对大多数第三代β-内酰胺类抗生素呈现高度耐药。有人提出这种耐药性是由于该酶对β-内酰胺类抗生素的非水解性结合或捕获。我们发现阴沟肠杆菌55M菌株的外膜对头孢唑啉的通透性确实比大肠杆菌低约14倍,并且该组成型突变体产生的β-内酰胺酶分子数量异常多(每个细胞2×10⁵个)。这些情况预计会产生低水平的耐药性,但无法解释该突变体的高耐药水平。我们表明该菌株的β-内酰胺酶能以可测量的速率水解第三代β-内酰胺类抗生素。尽管这些化合物的Vmax不到头孢唑啉的0.01%,但当底物浓度接近0.1微摩尔时,该酶能以与头孢唑啉相当的速率水解它们,由于该酶对许多第三代化合物具有极高的亲和力,这个浓度被认为与抑制细胞生长具有生理相关性。基于该酶的动力学参数、外膜通透性以及对青霉素结合蛋白的亲和力进行的计算成功预测了几种第三代β-内酰胺类抗生素的最低抑菌浓度(MIC)。数据表明,对于耐药表型的表达,水解作用可能比非水解性结合更重要,并且对β-内酰胺类抗生素对β-内酰胺酶敏感性的研究应在生理相关的极低药物浓度下进行,而不是在常规的非常高的浓度下,如100微摩尔。

相似文献

1
Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.β-内酰胺水解在产β-内酰胺酶的阴沟肠杆菌菌株对广谱β-内酰胺类抗生素耐药机制中的作用
Antimicrob Agents Chemother. 1985 Mar;27(3):393-8. doi: 10.1128/AAC.27.3.393.
2
Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae.β-内酰胺酶水解和外膜通透性对阴沟肠杆菌头孢曲松耐药性的作用
Antimicrob Agents Chemother. 1987 Oct;31(10):1589-95. doi: 10.1128/AAC.31.10.1589.
3
Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.由β-内酰胺类抗生素对阴沟肠杆菌的渗透减少所引起的耐药性。
Antimicrob Agents Chemother. 1985 Apr;27(4):555-60. doi: 10.1128/AAC.27.4.555.
4
Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae.β-内酰胺酶和外膜蛋白在阴沟肠杆菌多重β-内酰胺耐药中的作用
Antimicrob Agents Chemother. 1985 Apr;27(4):455-9. doi: 10.1128/AAC.27.4.455.
5
Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae.对新型β-内酰胺类药物抗阴沟肠杆菌疗效相关因素的重新评估。
Antimicrob Agents Chemother. 1991 Jan;35(1):73-8. doi: 10.1128/AAC.35.1.73.
6
Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.克服阴沟肠杆菌中头孢菌素酶介导的β-内酰胺耐药性的方法。
Chemioterapia. 1985 Feb;4(1):83-9.
7
Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance.肠杆菌中的广谱β-内酰胺耐药性:治疗期间的出现及耐药机制
J Antimicrob Chemother. 1983 Apr;11(4):299-310. doi: 10.1093/jac/11.4.299.
8
Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter.医院内分离的肠杆菌属细菌中β-内酰胺酶的表达及对β-内酰胺类抗生素的交叉耐药性
Chemotherapy. 1992;38(5):291-6. doi: 10.1159/000239016.
9
Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics.肠杆菌属细菌对β-内酰胺类抗生素的突变酶耐药性。
Antimicrob Agents Chemother. 1982 Apr;21(4):655-60. doi: 10.1128/AAC.21.4.655.
10
Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.影响阴沟肠杆菌和铜绿假单胞菌β-内酰胺酶诱导型菌株中β-内酰胺耐药性演变的因素。
J Infect Dis. 1987 May;155(5):936-41. doi: 10.1093/infdis/155.5.936.

引用本文的文献

1
Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health.细菌对抗菌药物的耐药性:机制、控制策略及其对全球健康的影响。
Sci Total Environ. 2023 Feb 20;860:160461. doi: 10.1016/j.scitotenv.2022.160461. Epub 2022 Nov 23.
2
Functional and Structural Roles of the Major Facilitator Superfamily Bacterial Multidrug Efflux Pumps.主要易化子超家族细菌多药外排泵的功能和结构作用
Microorganisms. 2020 Feb 16;8(2):266. doi: 10.3390/microorganisms8020266.
3
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
[Reversible specific concentration of amino acids in Escherichia coli].[大肠杆菌中氨基酸的可逆特异性浓度]
Ann Inst Pasteur (Paris). 1956 Nov;91(5):693-720.
3
Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.大肠杆菌中一种染色体头孢菌素酶介导的头孢西丁耐药性
头孢他啶-阿维巴坦联合磷霉素:一种治疗多重耐药铜绿假单胞菌的新策略。
J Infect Dis. 2019 Jul 19;220(4):666-676. doi: 10.1093/infdis/jiz149.
4
False-Positive Carbapenem-Hydrolyzing Confirmatory Tests Due to ACT-28, a Chromosomally Encoded AmpC with Weak Carbapenemase Activity from Enterobacter kobei.产 ACT-28 肠杆菌科细菌导致的碳青霉烯酶水解确证试验假阳性,ACT-28 是一种染色体编码的 AmpC,碳青霉烯酶活性较弱。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02388-18. Print 2019 May.
5
Applying ecological resistance and resilience to dissect bacterial antibiotic responses.运用生态阻力和弹性来剖析细菌对抗生素的反应。
Sci Adv. 2018 Dec 5;4(12):eaau1873. doi: 10.1126/sciadv.aau1873. eCollection 2018 Dec.
6
Past and Present Perspectives on β-Lactamases.β-内酰胺酶的过去与现在观点。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01076-18. Print 2018 Oct.
7
Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.肺炎克雷伯菌主要孔蛋白OmpK35和OmpK36比其大肠杆菌同源物OmpF和OmpC能更有效地促进β-内酰胺类药物的扩散。
J Bacteriol. 2016 Nov 4;198(23):3200-3208. doi: 10.1128/JB.00590-16. Print 2016 Dec 1.
8
Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.产超广谱β-内酰胺酶大肠埃希菌所致婴儿尿路感染:城乡医院比较
Pediatr Nephrol. 2016 Aug;31(8):1305-12. doi: 10.1007/s00467-016-3338-0. Epub 2016 Mar 14.
9
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2.抑制病原菌耐药性的产生:做好充分准备,第二部分
Antimicrob Agents Chemother. 2015 Dec 28;60(3):1194-201. doi: 10.1128/AAC.02231-15.
10
Bacterial temporal dynamics enable optimal design of antibiotic treatment.细菌的时间动态变化有助于优化抗生素治疗方案的设计。
PLoS Comput Biol. 2015 Apr 23;11(4):e1004201. doi: 10.1371/journal.pcbi.1004201. eCollection 2015 Apr.
J Antibiot (Tokyo). 1980 Sep;33(9):1037-42. doi: 10.7164/antibiotics.33.1037.
4
Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria.氨曲南及相关单环β-内酰胺类药物与革兰氏阴性菌β-内酰胺酶的相互作用。
Antimicrob Agents Chemother. 1982 Sep;22(3):414-20. doi: 10.1128/AAC.22.3.414.
5
Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.对头孢孟多的耐药性:头孢西丁对β-内酰胺酶的去阻遏作用及阴沟肠杆菌中的突变。
J Infect Dis. 1982 Jul;146(1):34-42. doi: 10.1093/infdis/146.1.34.
6
Purification and properties of a cephalosporinase from Enterobacter cloacae.阴沟肠杆菌头孢菌素酶的纯化及性质
Antimicrob Agents Chemother. 1980 Dec;18(6):853-7. doi: 10.1128/AAC.18.6.853.
7
Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.阴沟肠杆菌和铜绿假单胞菌中的头孢菌素酶截留不可水解头孢菌素作为一种可能的耐药机制。
Antimicrob Agents Chemother. 1982 May;21(5):711-7. doi: 10.1128/AAC.21.5.711.
8
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.新型广谱头孢菌素所选择的新型耐药性:一个值得关注的问题。
J Infect Dis. 1983 Mar;147(3):585-9. doi: 10.1093/infdis/147.3.585.
9
Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.阴沟肠杆菌的染色体β-内酰胺酶是导致对第三代头孢菌素耐药的原因。
Antimicrob Agents Chemother. 1983 Jun;23(6):918-25. doi: 10.1128/AAC.23.6.918.
10
Purification and characterization of two kinds of porins from the Enterobacter cloacae outer membrane.阴沟肠杆菌外膜中两种孔蛋白的纯化与特性分析
J Bacteriol. 1984 Jun;158(3):1179-81. doi: 10.1128/jb.158.3.1179-1181.1984.